Chariklia Giannopoulou. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Fluorodeoxyglucose F18HumansLambert-Eaton Myasthenic Syndrome/classificationLambert-Eaton Myasthenic Syndrome/diagnosisLambert-Eaton Myasthenic Syndrome/diagnostic imagingLambert-Eaton Myasthenic Syndrome/immunologyLimbic Encephalitis/classificationLimbic Encephalitis/diagnosisLimbic Encephalitis/diagnostic imagingLimbic Encephalitis/immunologyParaneoplastic Cerebellar Degeneration/classificationParaneoplastic Cerebellar Degeneration/diagnosisParaneoplastic Cerebellar Degeneration/diagnostic imagingParaneoplastic Cerebellar Degeneration/immunologyParaneoplastic Polyneuropathy/classificationParaneoplastic Polyneuropathy/diagnosisParaneoplastic Polyneuropathy/diagnostic imagingParaneoplastic Polyneuropathy/immunologyParaneoplastic Syndromes, Nervous System/classificationParaneoplastic Syndromes, Nervous System/diagnosisParaneoplastic Syndromes, Nervous System/diagnostic imagingParaneoplastic Syndromes, Nervous System/immunologyRadiopharmaceuticalsStiff-Person Syndrome/classificationStiff-Person Syndrome/diagnosisStiff-Person Syndrome/diagnostic imagingStiff-Person Syndrome/immunologyTomography, Emission-Computed/methods
Substances： See more » RadiopharmaceuticalsFluorodeoxyglucose F18
Year: 2003 PMID： 12722733 DOI： 10.1007/s00259-002-1005-0
Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236